# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-014654
Filing Date
2025-04-21
Accepted
2025-04-21 09:20:30
Documents
20
Period of Report
2025-06-03

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20047013x2_def14a.htm iXBRL | DEF 14A | 945467
6 | GRAPHIC | logo_adc2.jpg | GRAPHIC | 47456
7 | GRAPHIC | ny20047013x2_pc01.jpg | GRAPHIC | 489579
8 | GRAPHIC | ny20047013x2_pc02.jpg | GRAPHIC | 1633299
| Complete submission text file | 0001140361-25-014654.txt |  | 7250526

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | INLINE XBRL TAXONOMY EXTENSION - SCHEMA | adct-20250603.xsd | EX-101.SCH | 3087
3 | INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE | adct-20250603_def.xml | EX-101.DEF | 2506
4 | INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE | adct-20250603_lab.xml | EX-101.LAB | 1976
5 | INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE | adct-20250603_pre.xml | EX-101.PRE | 1657
23 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20047013x2_def14a_htm.xml | XML | 105953

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39071 | Film No.: 25851436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)